UNC Center for AIDS Research

It's about a real-life response to AIDS - a fierce commitment to creating and translating knowledge that advances the fight against HIV & AIDS

Acknowledge the CFAR Request A Service
  • About
    • Center Overview
    • Resources
      • HIV Matters Podcast Series
      • Training Tools
      • Related Organizations & Websites
    • Acknowledge the CFAR
    • Contact Us
  • Cores & Services
    • Administrative
      • CFAR Office of Community Engagement (OCE)
    • Biostatistics
    • Clinical
    • Clinical Pharmacology/Analytical Chemistry
    • Developmental
    • HIV/STD Laboratory (formerly VIM)
    • International
    • Social & Behavioral Science
  • Working Groups
  • Membership
  • News & Events
    • CFAR News & Announcements
    • CFAR Newsletters
    • Events Calendar
    • Friday Morning Conference
    • CFAR-Wide Webinar Series
    • 2019 Scientific Symposium
    • 2019 NCCC Community Symposium

CDC-UNC Collaboration Yields Potential Long-term HIV Protection

February 23, 2023

Rahima Benhabbour, PhD, MSc, associate professor of Biomedical Engineering, led a successful effort to create an injectable implant that can release effective HIV PrEP medications into the body for six months in non-human primates.

For people at high risk of contracting HIV, missing doses of their daily HIV prevention pills can have big consequences. In some cases, missing a pill can lead to lack of protection against the virus.

      Rahima Benhabbour, MSc, PhD

Since 2017, the lab of Rahima Benhabbour, PhD, MSc, associate professor in the UNC/NCSU Joint Department of Biomedical Engineering, has been working with a research team at the Centers for Disease Control and Prevention (CDC) consisting of J. Gerardo García-Lerma, MSc, PhD, Ivana Massud, PhD, and Charles Dobard, PhD and others at UNC, to develop an injectable implant that can release HIV pre-exposure prophylaxis (PrEP) medications into the body for a long period of time.

Their latest research, published in Nature Communications, shows that the team’s latest formulation can provide up to six months of full protection.

“This is the first time we showed 100% protection against multiple virus challenges in a macaque model of PrEP over an extended period of time,” said Benhabbour, “Our goal with this technology is a once or twice-yearly injection that could be self-administered.”

READ MORE

News

Recent Posts

  • UNC CFAR’s Biostatistics Core director Dr. Michael Hudgens honored with the 2023 Larsh Award
  • Dennis Research Group Releases New White Paper On Molecular HIV Epidemiology
  • CDC-UNC Collaboration Yields Potential Long-term HIV Protection
  • Alumni Gift Will Fund New Clinic in Malawi, Enhancing Research and Care for Reproductive Health and Sexually Transmitted Infections
  • Dr. Jeff Stringer Awarded Third Grant from Gates’ Foundation

GET IN TOUCH

UNC Center for AIDS Research
Lineberger Cancer Center
Chapel Hill, NC 27599
Email: prema_menezes@med.unc.edu

Follow Us

CFAR User Login
small_blue_trans
© 2018-2023 UNC CFAR. All rights reserved. Website by AndiSites Inc.